PROQR THERAPEUTICS NV (PRQR)

NL0010872495 - Common Stock

1.94  -0.02 (-1.02%)

After market: 1.98 +0.04 (+2.06%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
2.4M
-74.60%		4.8M
100.00%		9.525M
98.44%		14.841M
55.81%
EBITDA
YoY % growth
-54.86M
-37.12%		-62.2M
-13.38%		-29.346M
52.82%		-17.785M
39.39%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
-57.19M
-34.98%		-64.72M
-13.17%		-31.859M
50.77%		-27.057M
15.07%
Operating Margin
-2,382.92%-1,348.33%-334.48%-182.31%
EPS
YoY % growth
-0.97
-5.43%		-0.91
6.19%		-0.35
61.54%		-0.42
-18.66%		N/AN/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.11
-1.57%
Revenue
Q2Q % growth		3.2M
357.14%		N/AN/AN/AN/AN/AN/AN/AN/A
EBITDA
Q2Q % growth		-12.691MN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-7.124M
24.14%		N/AN/AN/AN/AN/AN/AN/AN/A

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -0.07
56.25%		0.01-0.08-732.51%
Q3 2023
Q2Q % growth		 -0.07
79.41%		-0.090.0219.37%
Q2 2023
Q2Q % growth		 -0.10
52.38%		-0.110.0111.76%
Q1 2023
Q2Q % growth		 -0.11
45.00%		-0.120.018.34%
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 6.215M
374.43%		15.027M-8.812M-58.64%
Q3 2023
Q2Q % growth		 1.37M
53.93%		3.383M-2.013M-59.50%
Q2 2023
Q2Q % growth		 1.24M
20.39%		1.242M-2K-0.16%
Q1 2023
Q2Q % growth		 700K
-43.09%		1.341M-641K-47.80%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-8.4% -26.24% -6.66% -9.92%
Revenue0% -10.01% 7.03% 28.44%